Charles Gaulin

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Current treatment options in oncology

Leukemia & lymphoma

Life (Basel, Switzerland)

Memorial Sloan Kettering Cancer Center

University of British Columbia (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan Kettering Cancer Center Sep 21 2016

United States

Chief Resident :: Gme-medicine

Mount Sinai Health System Jul 01 2016

United States

Resident Physician :: Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West

Education History

University of British Columbia

Canada

BSC

Publications

Rongjia Zhang, Susan Y Wu, Preetesh Jain, Chi Young Ok, Fangfang Yan, Wendy Chen, Onyeka Oriabure, Bouthaina Shbib Dabaja, Jillian R Gunther, Penny Fang, Chelsea Pinnix, Michael L Wang, Charles Gaulin
Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center. Leukemia & lymphoma (2024)
Charles Gaulin, Fiona Craig, Shannon Fortin Ensign, Ryan Robetorye, Sarah Gibson, Katalin Kelemen, Nandita Khera, Jose Leis, Mazie Tsang, Allison Rosenthal, Javier Munoz, Jeanne Palmer, Talal Hilal
Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms. Leukemia & lymphoma (2023)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi
Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm. Life (Basel, Switzerland) 12 (8) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Shannon P Fortin Ensign, Charles Gaulin, Maya Hrachova, Michael Ruff, Ehab Harahsheh, Kevin Vicenti, Januario Castro, Javier Munoz, Allison Rosenthal, Maciej M Mrugala
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current treatment options in oncology 23 (12) (2022)
Charles Gaulin, Angela Chan, Andriy Derkach, Jae H Park, Simon Mantha, Mark Blaine Geyer, Martin S Tallman
Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia. Leukemia & lymphoma 61 (10) (2020)

Charles Gaulin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Charles Gaulin